Global Follicle Stimulating Hormone Market Growth 2021-2026
According to this latest study, the 2021 growth of Follicle Stimulating Hormone will have significant change from previous year. By the most conservative estimates of global Follicle Stimulating Hormone market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1216.9 million in 2020. Over the next five years the Follicle Stimulating Hormone market will register a 2.9% CAGR in terms of revenue, the global market size will reach US$ 1364.6 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Follicle Stimulating Hormone market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Recombinant FSH
Urinary FSH
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Infertility Treatment
Assisted Reproductive Technology
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Follicle Stimulating Hormone Consumption 2016-2026
2.1.2 Follicle Stimulating Hormone Consumption CAGR by Region
2.2 Follicle Stimulating Hormone Segment by Type
2.2.1 Recombinant FSH
2.2.2 Urinary FSH
2.3 Follicle Stimulating Hormone Sales by Type
2.3.1 Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
2.3.2 Global Follicle Stimulating Hormone Revenue and Market Share by Type (2016-2021)
2.3.3 Global Follicle Stimulating Hormone Sale Price by Type (2016-2021)
2.4 Follicle Stimulating Hormone Segment by Application
2.4.1 Infertility Treatment
2.4.2 Assisted Reproductive Technology
2.5 Follicle Stimulating Hormone Sales by Application
2.5.1 Global Follicle Stimulating Hormone Sale Market Share by Application (2016-2021)
2.5.2 Global Follicle Stimulating Hormone Revenue and Market Share by Application (2016-2021)
2.5.3 Global Follicle Stimulating Hormone Sale Price by Application (2016-2021)
3 Global Follicle Stimulating Hormone by Company
3.1 Global Follicle Stimulating Hormone Sales Market Share by Company
3.1.1 Global Follicle Stimulating Hormone Sales by Company (2019-2021)
3.1.2 Global Follicle Stimulating Hormone Sales Market Share by Company (2019-2021)
3.2 Global Follicle Stimulating Hormone Revenue Market Share by Company
3.2.1 Global Follicle Stimulating Hormone Revenue by Company (2019-2021)
3.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Company (2019-2021)
3.3 Global Follicle Stimulating Hormone Sale Price by Company
3.4 Global Manufacturers Follicle Stimulating Hormone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Follicle Stimulating Hormone Product Location Distribution
3.4.2 Players Follicle Stimulating Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Follicle Stimulating Hormone by Region
4.1 Global Follicle Stimulating Hormone by Region
4.1.1 Global Follicle Stimulating Hormone Sales by Region
4.1.2 Global Follicle Stimulating Hormone Revenue by Region
4.2 Americas Follicle Stimulating Hormone Sales Growth
4.3 APAC Follicle Stimulating Hormone Sales Growth
4.4 Europe Follicle Stimulating Hormone Sales Growth
4.5 Middle East & Africa Follicle Stimulating Hormone Sales Growth
5 Americas
5.1 Americas Follicle Stimulating Hormone Sales by Country
5.1.1 Americas Follicle Stimulating Hormone Sales by Country (2016-2021)
5.1.2 Americas Follicle Stimulating Hormone Revenue by Country (2016-2021)
5.2 Americas Follicle Stimulating Hormone Sales by Type
5.3 Americas Follicle Stimulating Hormone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Follicle Stimulating Hormone Sales by Region
6.1.1 APAC Follicle Stimulating Hormone Sales by Region (2016-2021)
6.1.2 APAC Follicle Stimulating Hormone Revenue by Region (2016-2021)
6.2 APAC Follicle Stimulating Hormone Sales by Type
6.3 APAC Follicle Stimulating Hormone Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Follicle Stimulating Hormone by Country
7.1.1 Europe Follicle Stimulating Hormone Sales by Country (2016-2021)
7.1.2 Europe Follicle Stimulating Hormone Revenue by Country (2016-2021)
7.2 Europe Follicle Stimulating Hormone Sales by Type
7.3 Europe Follicle Stimulating Hormone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Follicle Stimulating Hormone by Country
8.1.1 Middle East & Africa Follicle Stimulating Hormone Sales by Country (2016-2021)
8.1.2 Middle East & Africa Follicle Stimulating Hormone Revenue by Country (2016-2021)
8.2 Middle East & Africa Follicle Stimulating Hormone Sales by Type
8.3 Middle East & Africa Follicle Stimulating Hormone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Follicle Stimulating Hormone Distributors
10.3 Follicle Stimulating Hormone Customer
11 Global Follicle Stimulating Hormone Market Forecast
11.1 Global Follicle Stimulating Hormone Forecast by Region
11.1.1 Global Follicle Stimulating Hormone Forecast by Regions (2021-2026)
11.2.2 Global Follicle Stimulating Hormone Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Follicle Stimulating Hormone Forecast by Type
11.7 Global Follicle Stimulating Hormone Forecast by Application
12 Key Players Analysis
12.1 Merck Serono
12.1.1 Merck Serono Company Information
12.1.2 Merck Serono Follicle Stimulating Hormone Product Offered
12.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck Serono Main Business Overview
12.1.5 Merck Serono Latest Developments
12.2 MSD
12.2.1 MSD Company Information
12.2.2 MSD Follicle Stimulating Hormone Product Offered
12.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 MSD Main Business Overview
12.2.5 MSD Latest Developments
12.3 IBSA
12.3.1 IBSA Company Information
12.3.2 IBSA Follicle Stimulating Hormone Product Offered
12.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 IBSA Main Business Overview
12.3.5 IBSA Latest Developments
12.4 Ferring
12.4.1 Ferring Company Information
12.4.2 Ferring Follicle Stimulating Hormone Product Offered
12.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Ferring Main Business Overview
12.4.5 Ferring Latest Developments
12.5 Livzon
12.5.1 Livzon Company Information
12.5.2 Livzon Follicle Stimulating Hormone Product Offered
12.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Livzon Main Business Overview
12.5.5 Livzon Latest Developments
12.6 Techwell
12.6.1 Techwell Company Information
12.6.2 Techwell Follicle Stimulating Hormone Product Offered
12.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Techwell Main Business Overview
12.6.5 Techwell Latest Developments
12.7 GenSci
12.7.1 GenSci Company Information
12.7.2 GenSci Follicle Stimulating Hormone Product Offered
12.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 GenSci Main Business Overview
12.7.5 GenSci Latest Developments
12.8 Gedeon Richter
12.8.1 Gedeon Richter Company Information
12.8.2 Gedeon Richter Follicle Stimulating Hormone Product Offered
12.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Gedeon Richter Main Business Overview
12.8.5 Gedeon Richter Latest Developments
12.9 Teva
12.9.1 Teva Company Information
12.9.2 Teva Follicle Stimulating Hormone Product Offered
12.9.3 Teva Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Teva Main Business Overview
12.9.5 Teva Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Follicle Stimulating Hormone Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Recombinant FSH
Table 3. Major Players of Urinary FSH
Table 4. Global Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 5. Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 6. Global Follicle Stimulating Hormone Revenue by Type (2016-2021) & ($ million)
Table 7. Global Follicle Stimulating Hormone Revenue Market Share by Type (2016-2021)
Table 8. Global Follicle Stimulating Hormone Sale Price by Type (2016-2021)
Table 9. Global Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 10. Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 11. Global Follicle Stimulating Hormone Value by Application (2016-2021)
Table 12. Global Follicle Stimulating Hormone Revenue Market Share by Application (2016-2021)
Table 13. Global Follicle Stimulating Hormone Sale Price by Application (2016-2021)
Table 14. Global Follicle Stimulating Hormone Sales by Company (2019-2021) & (K Doses)
Table 15. Global Follicle Stimulating Hormone Sales Market Share by Company (2019-2021)
Table 16. Global Follicle Stimulating Hormone Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Follicle Stimulating Hormone Revenue Market Share by Company (2019-2021)
Table 18. Global Follicle Stimulating Hormone Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Follicle Stimulating Hormone Producing Area Distribution and Sales Area
Table 20. Players Follicle Stimulating Hormone Products Offered
Table 21. Follicle Stimulating Hormone Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Follicle Stimulating Hormone Sales by Region (2016-2021) (K Doses)
Table 25. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Table 26. Global Follicle Stimulating Hormone Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021)
Table 28. Americas Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 29. Americas Follicle Stimulating Hormone Sales Market Share by Country (2016-2021)
Table 30. Americas Follicle Stimulating Hormone Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021)
Table 32. Americas Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 33. Americas Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 34. Americas Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 35. Americas Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 36. APAC Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 37. APAC Follicle Stimulating Hormone Sales Market Share by Region (2016-2021)
Table 38. APAC Follicle Stimulating Hormone Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021)
Table 40. APAC Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 41. APAC Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 42. APAC Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 43. APAC Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 44. Europe Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 45. Europe Follicle Stimulating Hormone Sales Market Share by Country (2016-2021)
Table 46. Europe Follicle Stimulating Hormone Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021)
Table 48. Europe Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 49. Europe Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 50. Europe Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 51. Europe Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 53. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Follicle Stimulating Hormone Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 57. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 59. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Follicle Stimulating Hormone
Table 61. Key Application and Potential Industries of Follicle Stimulating Hormone
Table 62. Key Challenges of Follicle Stimulating Hormone
Table 63. Key Trends of Follicle Stimulating Hormone
Table 64. Follicle Stimulating Hormone Distributors List
Table 65. Follicle Stimulating Hormone Customer List
Table 66. Global Follicle Stimulating Hormone Sales Forecast by Region (2021-2026) & (K Doses)
Table 67. Global Follicle Stimulating Hormone Consumption Market Forecast by Region
Table 68. Global Follicle Stimulating Hormone Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Follicle Stimulating Hormone Sales Forecast by Country (2021-2026) & (K Doses)
Table 71. Americas Follicle Stimulating Hormone Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Follicle Stimulating Hormone Sales Forecast by Region (2021-2026) & (K Doses)
Table 73. APAC Follicle Stimulating Hormone Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Follicle Stimulating Hormone Sales Forecast by Country (2021-2026) & (K Doses)
Table 75. Europe Follicle Stimulating Hormone Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Follicle Stimulating Hormone Sales Forecast by Country (2021-2026) & (K Doses)
Table 77. Middle East & Africa Follicle Stimulating Hormone Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Follicle Stimulating Hormone Sales Forecast by Type (2021-2026) & (K Doses)
Table 79. Global Follicle Stimulating Hormone Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Follicle Stimulating Hormone Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Follicle Stimulating Hormone Sales Forecast by Application (2021-2026) & (K Doses)
Table 83. Global Follicle Stimulating Hormone Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Follicle Stimulating Hormone Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Application (2021-2026)
Table 86. Merck Serono Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck Serono Follicle Stimulating Hormone Product Offered
Table 88. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 89. Merck Serono Main Business
Table 90. Merck Serono Latest Developments
Table 91. MSD Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 92. MSD Follicle Stimulating Hormone Product Offered
Table 93. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 94. MSD Main Business
Table 95. MSD Latest Developments
Table 96. IBSA Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 97. IBSA Follicle Stimulating Hormone Product Offered
Table 98. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 99. IBSA Main Business
Table 100. IBSA Latest Developments
Table 101. Ferring Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 102. Ferring Follicle Stimulating Hormone Product Offered
Table 103. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 104. Ferring Main Business
Table 105. Ferring Latest Developments
Table 106. Livzon Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 107. Livzon Follicle Stimulating Hormone Product Offered
Table 108. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 109. Livzon Main Business
Table 110. Livzon Latest Developments
Table 111. Techwell Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 112. Techwell Follicle Stimulating Hormone Product Offered
Table 113. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 114. Techwell Main Business
Table 115. Techwell Latest Developments
Table 116. GenSci Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 117. GenSci Follicle Stimulating Hormone Product Offered
Table 118. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 119. GenSci Main Business
Table 120. GenSci Latest Developments
Table 121. Gedeon Richter Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 122. Gedeon Richter Follicle Stimulating Hormone Product Offered
Table 123. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 124. Gedeon Richter Main Business
Table 125. Gedeon Richter Latest Developments
Table 126. Teva Basic Information, Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 127. Teva Follicle Stimulating Hormone Product Offered
Table 128. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 129. Teva Main Business
Table 130. Teva Latest Developments
List of Figures
Figure 1. Picture of Follicle Stimulating Hormone
Figure 2. Follicle Stimulating Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Follicle Stimulating Hormone Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Follicle Stimulating Hormone Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Follicle Stimulating Hormone Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Recombinant FSH
Figure 10. Product Picture of Urinary FSH
Figure 11. Global Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 12. Global Follicle Stimulating Hormone Revenue Market Share by Type (2016-2021)
Figure 13. Follicle Stimulating Hormone Consumed in Infertility Treatment
Figure 14. Global Follicle Stimulating Hormone Market: Infertility Treatment (2016-2021) & (K Doses)
Figure 15. Follicle Stimulating Hormone Consumed in Assisted Reproductive Technology
Figure 16. Global Follicle Stimulating Hormone Market: Assisted Reproductive Technology (2016-2021) & (K Doses)
Figure 17. Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2021)
Figure 18. Global Follicle Stimulating Hormone Revenue Market Share by Application in 2020
Figure 19. Follicle Stimulating Hormone Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Follicle Stimulating Hormone Revenue Market Share by Company in 2020
Figure 21. Global Follicle Stimulating Hormone Sales Market Share by Regions (2016-2021)
Figure 22. Global Follicle Stimulating Hormone Revenue Market Share by Region in 2020
Figure 23. Americas Follicle Stimulating Hormone Sales 2016-2021 (K Doses)
Figure 24. Americas Follicle Stimulating Hormone Revenue 2016-2021 ($ Millions)
Figure 25. APAC Follicle Stimulating Hormone Sales 2016-2021 (K Doses)
Figure 26. APAC Follicle Stimulating Hormone Revenue 2016-2021 ($ Millions)
Figure 27. Europe Follicle Stimulating Hormone Sales 2016-2021 (K Doses)
Figure 28. Europe Follicle Stimulating Hormone Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Follicle Stimulating Hormone Sales 2016-2021 (K Doses)
Figure 30. Middle East & Africa Follicle Stimulating Hormone Revenue 2016-2021 ($ Millions)
Figure 31. Americas Follicle Stimulating Hormone Sales Market Share by Country in 2020
Figure 32. Americas Follicle Stimulating Hormone Revenue Market Share by Country in 2020
Figure 33. Americas Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 34. Americas Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 35. United States Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Follicle Stimulating Hormone Sales Market Share by Region in 2020
Figure 40. APAC Follicle Stimulating Hormone Revenue Market Share by Regions in 2020
Figure 41. APAC Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 42. APAC Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 43. China Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Follicle Stimulating Hormone Sales Market Share by Country in 2020
Figure 50. Europe Follicle Stimulating Hormone Revenue Market Share by Country in 2020
Figure 51. Europe Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 52. Europe Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 53. Germany Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Follicle Stimulating Hormone Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Follicle Stimulating Hormone Sales Market Share by Application in 2020
Figure 62. Egypt Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Follicle Stimulating Hormone Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
